Drug Research
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced multiple advancements in its 4-1BB bispecific antibody portfolio. Stimulation...
Drug Research
Batavia to develop innovative clinical process for RocketVax’s second...
Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering. Under the agreement, Batavia will...
Drug Research
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology...
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with emerging...
Drug Research
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences...
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed an...
Drug Research
Oxford researchers launch HIV vaccine trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants.
The HIV-CORE 0052 trial,...
Drug Research
Roche & Mimetas collaborate to develop human disease models...
Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human disease models to characterize novel compounds in inflammatory bowel disease...
Drug Research
BioMed X and Merck KGaA, Darmstadt, Germany launch new...
BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program will...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.